Noble Financial Cuts Bacterin International (BONE) to Hold Following Concerning Outlook

Noble Financial downgraded shares of Bacterin International (NYSE: BONE) from Buy to Hold in an intraday research note Friday.

The downgrade follows Q1 results and the resulting 19 percent decline in the stock.

The company posted a quarterly loss of 3 cents per share and reduced its FY13 sales guidance from $53-$56 million to $35-$40 million. Analysts on the Street are currently expecting sales of $79.9 million.

For an analyst ratings summary and ratings history on Bacterin International click here. For more ratings news on Bacterin International click here.

Shares of Bacterin International closed at $1.77 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Downgrades Limbach Holdings (LMB) to Underweight
• JPMorgan Downgrades Kuaishou Technology (1024:HK) to Neutral
• RBC Capital Downgrades Super Retail Group Ltd. (SUL:AU) to Sector Perform